Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Ligand Pharmaceuticals (LGNYZ) Exchange Rate Effect (2018 - 2025)

Historic Exchange Rate Effect for Ligand Pharmaceuticals (LGNYZ) over the last 5 years, with Q3 2025 value amounting to -$400000.0.

  • Ligand Pharmaceuticals' Exchange Rate Effect fell 10770.42% to -$400000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year increase of 27188.33%. This contributed to the annual value of -$1.2 million for FY2024, which is N/A changed from last year.
  • As of Q3 2025, Ligand Pharmaceuticals' Exchange Rate Effect stood at -$400000.0, which was down 10770.42% from $27.6 million recorded in Q2 2025.
  • In the past 5 years, Ligand Pharmaceuticals' Exchange Rate Effect registered a high of $27.6 million during Q2 2025, and its lowest value of -$32.0 million during Q2 2024.